Showing 231-240 of 1717 results for "".
When to Consider a Second-Generation Wake-Promoting Drug
https://practicalneurology.com/diseases-diagnoses/sleep/PN0809_09-php/30900/Impaired Driving Related to Medications and Neurological Diagnoses
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/impaired-driving-related-to-medications-and-neurological-diagnoses/30686/Researchers investigated the degree to which various common agents, including benzodiazepines and non-benzodiazepine hypnotics, may affect driving ability. Therapy selection and patient counseling are key to safe use.Radiologic Biomarkers in Multiple Sclerosis: Improving Detection and Diagnosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/radiologic-biomarkers-in-multiple-sclerosis-improving-detection-and-diagnosis/54604/Imaging biomarkers, including cortical lesions, the central vein sign, and paramagnetic rim lesions, allow for more timely and accurate diagnosis of multiple sclerosis.Challenge Case Report: Aseptic Meningitis Worsening With Treatment
https://practicalneurology.com/diseases-diagnoses/imaging-testing/challenge-case-report-aseptic-meningitis-worsening-with-treatment/31610/Diagnosis should be re-evaluated when clinical situations change.Safety Monitoring of Disease-Modifying Therapies in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/safety-monitoring-of-disease-modifying-therapies-in-multiple-sclerosis/32085/Guidance in disease-modifying therapy selection and appropriate safety monitoring are important roles of the clinician caring for people with multiple sclerosis.Treating Early Relapsing Multiple Sclerosis: Induction & Escalation Approaches
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/treating-early-relapsing-multiple-sclerosis-induction-escalation-approaches/31873/Evidence-based clinical trial results are needed to guide this difficult decision-making processSpecial Report: Inside the AED Development Process
https://practicalneurology.com/columns/practice-management/special-report-inside-the-aed-development-process/30845/MOG Antibody Disease
https://practicalneurology.com/diseases-diagnoses/imaging-testing/mog-antibody-disease/31924/This case of myelin oligodendrocyte glycoprotein (MOG) antibody disease was unusual in that both central and peripheral demyelination were present.Lingual Dysarthia
https://practicalneurology.com/diseases-diagnoses/neuromuscular/lingual-dysarthia/30503/Visualizing Concussions
https://practicalneurology.com/diseases-diagnoses/tbi/visualizing-concussions/30400/